Monitoring insulin aggregation via capillary electrophoresis

International Journal of Molecular Sciences

Volumn 12, Issue 12, 2011, Pages 9369-9388

  Pryor, Elizabeth ^a   Kotarek, Joseph A ^b,c   Moss, Melissa A ^b   Hestekin, Christa N ^a  

^a 3202 Bell Engineering Center   (United States)

^b University of South Carolina   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Amyloid; Capillary electrophoresis; Insulin; Laser induced fluorescence; Oligomer; Thioflavin T; Ultraviolet absorbance

Indexed keywords

AMYLOID PROTEIN; FLUORESCEIN ISOTHIOCYANATE; INSULIN; THIOFLAVINE;

ARTICLE; BETA SHEET; CAPILLARY ELECTROPHORESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; INTERMETHOD COMPARISON; IONIC STRENGTH; LIGHT ABSORPTION; LIMIT OF DETECTION; MOLECULAR WEIGHT; NONHUMAN; PH MEASUREMENT; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DETERMINATION; REACTION TIME; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; POLYMERIZATION; PROCEDURES; RADIATION ABSORPTION;

ABSORPTION, RADIATION; ELECTROPHORESIS, CAPILLARY; HUMANS; INSULIN; LIMIT OF DETECTION; POLYMERIZATION;

EID: 84055190997     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12129369     Document Type: Article

References (84)

1. Hales, C.N. The role of insulin in the regulation of glucose metabolism. Symp. Proc. 1971, 30, 282-288.
2. Blundell, T.; Dodson, G.; Hodgkin, D.; Mercola, D. Insulin: Structure in the crystal and its reflection in chemistry and biology. Adv. Protein Chem. 1972, 26, 279-402.
3. Grudzielanek, S.; Smirnovas, V. Solvation-assisted pressure tuning of insulin fibrillation: From novel aggregation pathways to biotechnological applications. J. Mol. Biol. 2006, 356, 497-509.
4. Waugh, D.F.; Wilhelmson, D.F. Studies of the nucleation and growth reactions of selected types of insulin fibrils. J. Am. Chem. Soc. 1953, 75, 2592-2600.
5. Nielsen, L.; Khurana, R.; Fink, A. Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism. Biochemistry 2001, 40, 6036-6046.
6. Dobson, C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24, 329-332.
7. Sluzky, V.; Tamada, J.; Klibanov, A.; Langer, R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. USA 1991, 88, 9377-9381.
8. Jeffrey, P.; Milthorpe, B.; Nichol, L. Polymerization pattern of insulin at pH 7.0. Biochemistry 1976, 15, 4660-4665.
9. Dische, F.E.; Wernstedt, C. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988, 31, 158-161.
10. Brange, J.; Andersen, L. Toward understanding insulin fibrillation. J. Pharm. Sci. 1997, 86, 517-525.
11. Shikama, Y.; Kitazawa, J.; Yagihashi, N.; Uehara, O.; Murata, Y.; Yajima, N.; Wada, R.; Yagihashi, S. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med. 2010, 49, 397-401.
12. Mauro, M.; Craparo, E. Kinetics of different processes in human insulin amyloid formation. J. Mol. Biol. 2007, 366, 258-274.
13. Herman, W.; Ilag, L. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005, 28, 1568-1573.
14. Grudzielanek, S.; Velkova, A. Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways. J. Mol. Biol. 2007, 370, 372-384.
15. Carulla, N.; Zhou, M.; Giralt, E.; Robinson, C.; Dobson, C. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange. Acc. Chem. Res. 2010, 43, 1072-1079.
16. Ahmad, A.; Uversky, V.; Hong, D.; Fink, A. Early events in the fibrillation of monomeric insulin. J. Biol. Chem. 2005, 280, 42669-42675.
17. Iurascu, M.; Cozma, C.; Tomczyk, N.; Rontree, J.; Desor, M.; Drescher, M.; Przybylski, M. Structural characterization of β-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy. Anal. Bioanal. Chem. 2009, 395, 2509-2519.
18. Maji, S.; Ogorzalek Loo, R.; Inayathullah, M.; Spring, S.; Vollers, S.; Condron, M.; Bitan, G.; Loo, J.; Teplow, D. Amino acid position-specific contributions to amyloid β-protein oligomerization. J. Biol. Chem. 2009, 284, 23580-23591.
19. Palmblad, M.; Westlind-Danielsson, A.; Bergquist, J. Oxidation of methionine 35 attenuates formation of amyloid β-peptide 1-40 oligomers. J. Biol. Chem. 2002, 277, 19506-19510.
20. 19 alloform. J. Am. Chem. Soc. 2005, 127, 2075-2084.
21. Bernstein, S.; Dupuis, N.; Lazo, N.; Wyttenbach, T.; Condron, M.; Bitan, G.; Teplow, D.; Shea, J.; Ruotolo, B.; Robinson, C.; et al. Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat. Chem. 2009, 1, 326-331.
22. Bitan, G.; Kirkitadze, M.; Lomakin, A.; Vollers, S.; Benedek, G.; Teplow, D. Amyloid β -protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 2003, 100, 330-335.
23. Murray, M.; Bernstein, S.; Nyugen, V.; Condron, M.; Teplow, D.; Bowers, M. Amyloid β protein: Aβ40 inhibits Aβ42 oligomerization. J. Am. Chem. Soc. 2009, 131, 6316-6317.
24. Kayed, R.; Head, E.; Thompson, J.L.; McIntire, T.M.; Milton, S.C.; Cotman, C.W.; Glabe, C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300, 486-489.
25. Kayed, R.; Head, E.; Sarsoza, F.; Saing, T.; Cotman, C.W.; Necula, M.; Margol, L.; Wu, J.; Breydo, L.; Thompson, J.L.; et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2007, 2, doi:10.1186/1750-1326-2-18.
26. Ladiwala, A.; Lin, J.; Bale, S.; Marcelino-Cruz, A.; Bhattacharya, M.; Dordick, J.; Tessier, P. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Aβ into off-pathway conformers. J. Biol. Chem. 2010, 285, 24228-24237.
27. Podlisny, M.; Walsh, D.; Selkoe, D. Oligomerization of endogeneous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by congo red. Biochemistry 1998, 37, 3602-3611.
28. Ward, R.; Jennings, K.; Howlett, D. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide. Biochem. J. 2000, 348, 137-144.
29. Zhang, Y.; Wang, X.; He, J.-S.; Bao, F.-X.; Sun, W.-M.; Dai, X.-X.; Wang, X.-B.; Li, Y.-Q.; Zhen, X.-X.; Hu, H.-G.; et al. Preparation and characterization of a monoclonal antibody with high affinity for soluble Aβ oligomers. Hybridoma 2009, 28, 349-354.
30. Satoh, Y.; Hirakura, Y.; Kirino, Y. B-amyloid peptides inhibit acetylcholine release from cholinergic presynaptic nerve endings isolated from an electric ray. Neurosci. Lett. 2001, 302, 97-100.
31. Lambert, M.P.; Barlow, A.K.; Chromy, B.A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T.E.; Rozovsky, I.; Trommer, B.; Viola, K.L.; et al. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 1998, 95, 6448-6453.
32. Stine, W.B., Jr.; Dahlgren, K.N.; Krafft, G.A.; LaDu, M.J. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 2003, 278, 11612-11622.
33. Walsh, D.; Tseng, B.; Rydel, R.; Podlisny, M.; Selkoe, D. The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry 2000, 39, 10831-10839.
34. 692 → Gly) Alzheimer's disease. Biochem. J. 2001, 355, 869-877.
35. Walsh, D.; Klyubin, I.; Fadeeva, J.; Cullen, W.; Anwyl, R.; Wolfe, M.; Rowan, M.; Selkoe, D. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416, 535-539.
36. Ryan, D.; Narrow, W.; Federoff, H.; Bowers, W. An improved method for generating consistent soluble amyloid-β oligomer preparations for in vitro neurotoxicity studies. J. Neurosci. Methods 2010, 190, 171-179.
37. Dahlgren, K.N.; Manelli, A.M.; Stine, W.B., Jr.; Baker, L.K.; Krafft, G.A.; LaDu, M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 2002, 277, 32046-32053.
38. Kato, M.; Kinoshita, H.; Toyo'oka, T. Analytical method for β-amyloid fibrils using CE-laser induced fluorescence and its application to screening for inhibitors of β-amyloid protein aggregation. Anal. Chem. 2007, 79, 4887-4891.
39. Lee, J.; Ryu, J.; Park, C.B. High-throughput analysis of Alzheimer's β-amyloid aggregation using a microfluidic self-assembly of monomers. Anal. Chem. 2009, 81, 2751-2759.
40. Picou, R.; Kheterpal, I.; Wellman, A.; Minnamreddy, M.; Ku, G.; Gilman, S.D. Analysis of Aβ(1-40) and Aβ(1-42) monomer and fibrils by capillary electrophoresis. J. Chromatogr. B 2011, 879, 627-632.
41. Sabella, S.; Quaglia, M.; Lanni, C.; Racchi, M.; Govoni, S.; Caccialanza, G.; Calligaro, A.; Bellotti, V.; Lorenzi, E. Capillary electrophoresis studies on the aggregation process of β-amyloid 1-42 and 1-40 peptides. Electrophoresis 2004, 25, 3186-3194.
42. Ortner, K.; Buchberger, W. Capillary electrokinetic chromatography of insulin and related synthetic analogues. J. Chromatogr. A 2009, 1216, 2953-2957.
43. Brambilla, D.; Verpillot, R.; Taverna, M.; De Kimpe, L.; Le Droumagust, B.; Nicolas, J.; Canovi, M.; Gobbi, M.; Mantegazza, F.; Salmona, M.; et al. New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide. Anal. Chem. 2010, 82, 10083-10089.
44. Sureshbabu, N.; Kirubagaran, R.; Jayakumar, R. Surfactant-induced conformational transition of amyloid β-peptide. Eur. Biophys. J. 2009, 38, 355-367.
45. Yamamoto, S.; Hasegawa, K.; Yamaguchi, I.; Tsutsumi, S.; Kardos, J.; Goto, Y.; Gejyo, F.; Naiki, H. Low concentrations of sodium dodecyl sulfate induce the extension of β2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 2004, 43, 11075-11082.
46. Bitan, G.; Fradinger, E.A.; Spring, S.M.; Teplow, D.B. Neurotoxic protein oligomers-What you see is not always what you get. Amyloid 2005, 12, 88-95.
47. Fukuyama, R.; Mizuno, T.; Mori, S.; Nakajima, K.; Fushiki, S.; Yanagisawa, K. Age-dependent change in the levels of Aβ40 and Aβ42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Aβ42 to Aβ40 level in cerebrospinal fluid from Alzheimer's disease patients. Eur. Neurol. 2000, 43, 155-160.
48. Lewczuk, P.; Esselmann, H.; Otto, M.; Maler, J.M.; Henkel, A.W.; Henkel, M.K.; Eikenberg, O.; Antz, C.; Krause, W.R.; Reulbach, U.; et al. Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau. Neurobiol. Aging 2004, 25, 273-281.
49. Zuberovic, A.; Hanrieder, J.; Wetterhall, M. Proteome profiling of human cerebrospinal fluid: Exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples. Eur. J. Mass Spectrom. 2008, 14, 249-260.
50. Pinto, D.; Arriaga, E.; Dovichi, N. Solid-phase fluorescent labeling reaction of picomole amounts of insulin in very dilute solutions and their analysis by capillary electrophoresis. Electrophoresis 1995, 16, 534-540.
51. Shihabi, Z.; Friedberg, M. Insulin stacking for capillary electrophoresis. J. Chromatogr. A 1998, 807, 129-133.
52. Kunkel, A.; Gunter, S.; Watzig, H. Quantitation of insulin by capillary electrophoresis and high-performance liquid chromatography Method comparison and validation. J. Chromatogr. A 1997, 781, 445-455.
53. Yu, C.; Chin, C. In situ probing of insulin aggregation in chromatography effluents with spectroturbidimetry. J. Colloid Interface Sci. 2006, 299, 733-739.
54. Nayak, A.; Sorci, M.; Krueger, S.; Belfort, G. A universal pathway for amyloid nucleus and precursor formation for insulin. Proteins 2008, 74, 556-565.
55. Nettleton, E.; Tito, P. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 2000, 79, 1053-1065.
56. Vestergaard, B.; Groenning, M.; Roessle, M.; Kastrup, J.S.; van de Weert, M.; Flink, J.M.; Frokjaer, S.; Gajhede, M.; Svergun, D.I. A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol. 2007, 5, 1089-1097.
57. Fodera, V.; Librizzi, F.; Leone, M. Secondary nucleation and accessible surface in insulin amyloid fibril formation. J. Phys. Chem. 2007, 112, 3853-3858.
58. Seyrek, E.; Dubin, P.; Tribet, C.; Gamble, E. Ionic strength dependence of protein-polyelectrolyte interactions. Biomacromolecules 2003, 4, 273-282.
59. Giger, K.; Vanam, R.P.; Seyrek, E.; Dubin, P.L. Suppression of insulin aggregation by heparin. Biomacromolecules 2008, 9, 2338-2344.
60. LeVine, H. Thioflavine T Interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 1993, 2, 404-410.
61. Nielsen, L.; Frokjaer, S. Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 2001, 40, 8397-8409.
62. Ahmad, A.; Millett, I. Partially folded intermediates in insulin fibrillation. Biochemistry 2003, 42, 11404-11416.
63. Sasahara, K.; Yagi, H.; Sakai, M.; Naiki, H.; Goto, Y. Amyloid nucleation triggered by agitation of β2-microglobulin under acidic and neutral pH conditions. Biochemistry 2008, 47, 2650-2660.
64. Picotti, P.; Franceschi, G.; Frare, E.; Spolaore, B.; Zambonin, M.; Chiti, F.; Polverino de Laureto, P.; Fontana, A. Amyloid fibril formation and disaggregation of fragment 1-29 of apomyoglobin: Insights into the effect of pH on protein fibrillogenesis. J. Mol. Biol. 2007, 367, 1237-1245.
65. Jain, S.; Udgaonkar, J. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein. J. Mol. Biol. 2008, 382, 1228-1241.
66. Lin, M.; Chen, L.; Tsai, H.; Wang, S.; Chang, Y.; Higuchi, A.; Chen, W. Investigation of the mechanism of β-amyloid fibril formation by kinetic and thermodynamic analyses. Langmuir 2008, 24, 5802-5808.
67. 2+ store in porcine coronary artery smooth muscle. Diabetes 1996, 45, 876-880.
68. Lee, Y.-H.; Maus, R.G.; Smith, B.W.; Winefordner, J.D. Laser-induced fluorescence detection of a single molecule in a capillary. Anal. Chem. 1994, 66, 4142-4149.
69. Skeidsvoll, J.; Ueland, P. Analysis of double-stranded DNA by capillary electrophoresis with laser-induced fluorescence detection using the monomeric dye SYBR green I. Anal. Biochem. 1995, 231, 359-365.
70. Lim, H.B.; Lee, J.J.; Lee, K. Simple and sensitive laser-induced fluorescence detection for capillary electrophoresis and its application to protein separation. Electrophoresis 1995, 16, 674-678.
71. Ren, J.; Li, B.; Deng, Y.; Cheng, J. Indirect thermo-optical detection for capillary electrophoresis. Talanta 1995, 42, 1891-1895.
72. Brange, J.; Skelbaek-Pedersen, B. The Physicochemical and Pharmaceutical Aspects of Insulin and Insulin Preparations. In Galenics of Insulin; Springer-Verlag: Berlin, Germany, 1987; pp. 369-319, 370-456.
73. Grudzielanek, S.; Jansen, R. Solvational tuning of the unfolding, aggregation and amyloidogenesis of insulin. J. Mol. Biol. 2005, 351, 879-894.
74. Schultz, N.; Kennedy, R. Rapid immunoassays using capillary electrophoresis with fluorescence detection. Anal. Chem. 1993, 65, 3161-3165.
75. Tao, L.; Kennedy, R. On-line competitive immunoassay for insulin based on capillary electrophoresis with laser-induced fluorescence detection. Anal. Chem. 1996, 68, 3899-3906.
76. Nichols, M.; Moss, M.; Rosenberry, T. Growth of β -amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry 2002, 41, 6115-6127.
77. Gu, X.; Greiner, E.R.; Mishra, R.; Kodali, R.; Osmand, A.; Finkbeiner, S.; Steffan, J.S.; Thompson, L.M.; Wetzel, R.; Yang, X.W. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 2009, 64, 828-840.
78. Morshedi, D.; Ebrahim-Habibi, A.; Moosavi-Movahedi, A.A.; Nemat-Gorgani, M. Chemical modification of lysine residues in lysozyme may dramatically influence its amyloid fibrillation. Biochim. Biophys. Acta (BBA) 2010, 1804, 714-722.
79. Choi, S.; Connelly, S.; Reixach, N.; Wilson, I.A.; Kelly, J.W. Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasma. Nat. Chem. Biol. 2010, 6, 133-139.
80. DeFelippis, M.R.; Bakaysa, D.L.; Bell, M.A.; Heady, M.A.; Li, S.; Pye, S.; Youngman, K.M.; Radziuk, J.; Frank, B.H. Preparation and characterization of a cocryst. Suspension of [LysB28,ProB29]-human insulin analog. J. Pharm. Sci. 1998, 87, 170-176.
81. Kotzke, G.; Schuett, M.; Missler, U.; Moller, D.E.; Fehm, H.L.; Klein, H.H. Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms. Diabetologia 1995, 38, 757-763.
82. Moses, S. Bovine Porcine and Human Insulin. A Present Day Comparative Appraisal and Policy Discussions, 1st ed.; IDDT (Insulin Dependent Diabetes Trust): Chennai, India, 2002.
83. Albarghouthi, M.; Stein, T.; Barron, A. Poly-N-hydroxyethylacrylamide as a novel, adsorbed coating for protein separation by capillary electrophoresis. Electrophoresis 2003, 24, 1166-1175.
84. Davis, T.J.; Soto-Ortega, D.D.; Kotarek, J.A.; Gonzalez-Velasquez, F.J.; Sivakumar, K.; Wu, L.; Wang, Q.; Moss, M.A. Comparative study of inhibition at multiple stages of amyloid-β self assembly provides mechanistic insight. Mol. Pharmacol. 2009, 76, 405-413.